LIVINGCELL ApS: Financial statements 2024
CVR: 27205607
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
LIVINGCELL ApS (CVR 27205607) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -24,191 and a net result of DKK -17,604 compared with DKK 267,779 the year before. Equity in the 2024 report amounted to DKK 122,450. The solvency ratio was 75.6%.
- Gross Profit
- DKK -24,191
- Profit/Loss
- DKK -17,604
- Equity
- DKK 122,450
- Total Assets
- DKK 161,973
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -24 t. | -18 t. | 122 t. | - |
| 2023 | - | 344 t. | 268 t. | 405 t. | - |
| 2022 | - | 326 t. | 251 t. | 387 t. | - |
| 2021 | - | 365 t. | 282 t. | 416 t. | - |
| 2020 | - | 298 t. | 228 t. | 362 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout LIVINGCELL ApS
LIVINGCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Anders Bek-Pedersen. The board consists of Anders Bek-Pedersen (chair). The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 0 employees (2004). In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908.